RESTEM is a leading clinical-stage biotechnology company focused ... San Antonio Breast Cancer Symposium · NEWS · NATION · REGIONS · BUSINESS · WORLD.
News
- RESTEM Announces First-Patient-Dosed in the Phase 1/2a Study of Restem-L ... - The Manila Times
- Trump calls out Cuellar days after pardon, faults him for not switching parties - Texas Public Radio
The Cook Political Report rates District 28, which spans from San Antonio to Laredo to the Rio Grande Valley, as a tossup. TPR was founded by and is ...
- Menarini Group Presents Elacestrant (ORSERDU®) Phase 2 Combination Data in Patients ...
These data will be presented at the 2025 San Antonio Breast Cancer Symposium (SABCS), December 9-12. ... Crescent, Kelun-Biotech Swap Therapies in ADC- ...
- SABCS 2025: REVEAL GENOMICS Presents Major Advance in Predicting Brain Metastasis ...
BARCELONA, Spain--(BUSINESS WIRE)--REVEAL GENOMICS, S.L., a Barcelona-based biotechnology ... San Antonio Breast Cancer Symposium (SABCS) 2025, held ...
- First Blood Donor Center blood drive at Health Science Center campus a success
... San Antonio Multispecialty and Research Hospital on June 3. The UT Health San Antonio Blood Donor Center recently hosted its first blood drive ...